Elevance Health (ELV) Long-Term Investments (2009 - 2026)

Elevance Health (ELV) has 18 years of Long-Term Investments data on file, last reported at $11.1 billion in Q2 2026.

• On a quarterly basis, Long-Term Investments rose 923.92% year-over-year to $11.1 billion in Q2 2026; TTM through Jun 2026 was $11.1 billion, a 923.92% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 8.31% from the prior year.
• Long-Term Investments for Q2 2026 stood at $11.1 billion, up from $1.1 billion in the prior quarter.
• Over the last five years, Long-Term Investments for ELV reached as high as $11.1 billion in Q2 2026 and fell as low as $467.0 million in Q2 2022.
• Historically, Long-Term Investments has averaged $2.0 billion across 5 years, with a median of $964.0 million in 2024.
• Across the five-year window, Long-Term Investments jumped 1043.55% in 2023 and tumbled 85.4% in 2024, its largest moves.
• Year by year, Long-Term Investments stood at $581.0 million in 2022, then soared by 50.77% to $876.0 million in 2023, then advanced by 18.15% to $1.0 billion in 2024, then advanced by 8.31% to $1.1 billion in 2025, then jumped by 892.86% to $11.1 billion in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $11.1 billion in Q2 2026, $1.1 billion in Q1 2026, and $1.1 billion in Q4 2025.